Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947263-25-000010
Filing Date
2025-11-14
Accepted
2025-11-14 11:26:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5264
  Complete submission text file 0000947263-25-000010.txt   7049
Mailing Address 66 WELLINGTON STREET WEST 12TH FLOOR, TD TOWER TORONTO, ONTARIO A6 M5K 1A2
Business Address 66 WELLINGTON STREET WEST 12TH FLOOR, TD TOWER TORONTO, ONTARIO A6 M5K 1A2 416-944-6367
TORONTO DOMINION BANK (Filed by) CIK: 0000947263 (see all company filings)

EIN.: 135640479 | State of Incorp.: A6 | Fiscal Year End: 1031
Type: SCHEDULE 13G
SIC: 6029 Commercial Banks, NEC
(CF Office: 02 Finance)

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Subject) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89992 | Film No.: 251482925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)